ClinicalTrials.gov
public full text
Public Domain
Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis
Study of the efficacy, safety, tolerability, pharmacokinetics (PK), and immunogenicity of Vixarelimab (KPL-716) in subjects with prurigo nodularis (PN).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dupilumab for recalcitrant prurigo nodularis: Case report#335990
- BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris#834791
- Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa#1010772
- FORMULASI DAN UJI AKTIVITAS ANTIBAKTERI SEDIAAN FACIAL WASH EKSTRAK ETANOL DAUN MENTENG (Baccaurea racemosa) TERHADAP Propionibacterium acnes#453750
- Effect of vitk2 on Atopic Dermatitis Pediatrics Patients#1032161
Record · ID 1057043
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive